Eli Lilly Stock Surges as Weight Loss Drugs Continue to Fuel Growth

Key TakeawaysEli Lilly shares jumped in early trading Tuesday as the drugmaker reported first-quarter earnings above expectations and raised full year revenue and earnings guidance.Weight-loss drugs Mounjaro and Zepbound continue to be massive revenue drivers for the company as demand has soared in recent years.The stock, which has nearly doubled in the past year, is on track to set a new record high Tuesday. Eli Lilly (LLY) stock jumped in early trading Tuesday after the drugmaker reported first-quarter ea ...